This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Laboratoire L. Lafon, Teva Sante. Active years: 1998-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2013
Title: Innovations of Thanh-Tam Nguyen
Introduction
Thanh-Tam Nguyen is an accomplished inventor based in Limeil-Brevannes, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, Nguyen has demonstrated a commitment to advancing medical science.
Latest Patents
Nguyen's latest patents include a formulation for an oral lyophilizate comprising modafinil particles. This invention focuses on modafinil particles with a median diameter ranging from about 10 to about 1000 micrometers, combined with various excipients such as fatty acid esters of glycerol and cyclic oligosaccharides. His second patent involves a novel process for preparing particles that contain an excipient forming a matrix and at least one active ingredient. This process utilizes extrusion followed by lyophilization, ensuring a uniform distribution of the active ingredient within the matrix.
Career Highlights
Throughout his career, Thanh-Tam Nguyen has worked with notable companies in the pharmaceutical industry, including Laboratoire L. Lafon and Teva Santé. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation and delivery.
Collaborations
Nguyen has collaborated with esteemed colleagues such as Joelle Jacquot-Leyder and Joëlle Leyder. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thanh-Tam Nguyen's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile